July 12, 2018
Via: Mass DeviceAbbott (NYSE:ABT) won FDA approval for the third generation of its MitraClip transcatheter heart valve repair device, the company said today. Acquired in the $410 million acquisition of Evalve back in 2009, MitraClip won its first FDA nod in 2013. […]
July 9, 2024
June 25, 2024